Delivery Order SPE2DB24D1034-SPE2DB25FWCD5
Award Date
4/17/25
Potential Completion Date
4/18/25
Potential Value
$18K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $22,390.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of Vraylar 1.5 mg capsules, a medication used to treat various mental health conditions. The contract has a firm fixed price pricing type and an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $6,842.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Vraylar 1.5 mg capsules and is a firm fixed-price delivery order contract with an ultimate completion date of April 18, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $2,832.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Vraylar 1.5 mg capsules, a medication used to treat certain mental health conditions. The contract has a firm fixed price and an ultimate completion date of April 21, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $1,115.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4.5 mg Vraylar capsules, a prescription medication, with a performance period through April 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global...
This federal contract award, valued at $13,671.94, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vraylar 1.5 mg capsules, a medication used to treat certain mental health conditions. This is a Firm Fixed Price Delivery Order contract with a completion date of January 7, 2025. The contract is not designated as a set-aside award, indicating open...
This federal contract award, valued at $58,088.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,567,925,531 units of the prescription medication Vraylar 1.5 mg capsules. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,220.74 firm fixed-price delivery order is for the supply of Vraylar 1.5 mg capsules, a neurological medication. The contract has an ultimate completion date of April 21, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $3,696.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Vraylar 4.5 mg capsules, a neurological medication. The contract is not set aside and is a firm fixed-price arrangement with an ultimate completion date of April 21, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a $16,318.05 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract is to supply the DLA with Vraylar 3 mg capsules, a medication used for the treatment of mental health conditions. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This federal contract award, valued at $34,509.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical. This IDC serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical...